Wamil Malgorzata, Andrew Ruth, Chapman Karen E, Street Jonathan, Morton Nicholas M, Seckl Jonathan R
Endocrinology Unit, Centre for Cardiovascular Science, The Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, United Kingdom.
Endocrinology. 2008 Dec;149(12):5909-18. doi: 10.1210/en.2008-0420. Epub 2008 Aug 28.
Obesity is associated with an increased risk of diabetes type 2, dyslipidemia, and atherosclerosis. These cardiovascular and metabolic abnormalities are exacerbated by excessive dietary fat, particularly cholesterol and its metabolites. High adipose tissue glucocorticoid levels, generated by the intracellular enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1), are also implicated in the pathogenesis of obesity, metabolic syndrome, and atherosclerosis. 11beta-HSD1 also interconverts the atherogenic oxysterols 7-ketocholesterol (7KC) and 7beta-hydroxycholesterol (7beta-HC). Here, we report that 11beta-HSD1 catalyzes the reduction of 7KC to 7beta-HC in mature 3T3-L1 and 3T3-F442A adipocytes, leading to cellular accumulation of 7beta-HC. Approximately 73% of added 7KC was reduced to 7beta-HC within 24 h; this conversion was prevented by selective inhibition of 11beta-HSD1. Oxysterol and glucocorticoid conversion by 11beta-HSD1 was competitive and occurred with a physiologically relevant IC(50) range of 450 nm for 7KC inhibition of glucocorticoid metabolism. Working as an inhibitor of 11beta-reductase activity, 7KC decreased the regeneration of active glucocorticoid and limited the process of differentiation of 3T3-L1 preadipocytes. 7KC and 7beta-HC did not activate liver X receptor in a transactivation assay, nor did they display intrinsic activation of the glucocorticoid receptor. However, when coincubated with glucocorticoid (10 nm), 7KC repressed, and 7beta-HC enhanced, glucocorticoid receptor transcriptional activity. The effect of 7-oxysterols resulted from the modulation of 11beta-HSD1 reaction direction, and could be ameliorated by overexpression of hexose 6-phosphate dehydrogenase, which supplies reduced nicotinamide adenine dinucleotide phosphate to 11beta-HSD1. Thus, the activity and reaction direction of adipose 11beta-HSD1 is altered under conditions of oxysterol excess, and could impact upon the pathophysiology of obesity and its complications.
肥胖与2型糖尿病、血脂异常和动脉粥样硬化风险增加相关。这些心血管和代谢异常会因过多的膳食脂肪而加剧,尤其是胆固醇及其代谢产物。由细胞内11β-羟基类固醇脱氢酶1型(11β-HSD1)产生的高脂肪组织糖皮质激素水平也与肥胖、代谢综合征和动脉粥样硬化的发病机制有关。11β-HSD1还能使致动脉粥样硬化的氧化甾醇7-酮胆固醇(7KC)和7β-羟基胆固醇(7β-HC)相互转化。在此,我们报告11β-HSD1在成熟的3T3-L1和3T3-F442A脂肪细胞中催化7KC还原为7β-HC,导致7β-HC在细胞内积累。在24小时内,约73%添加的7KC被还原为7β-HC;这种转化可通过选择性抑制11β-HSD1来阻止。11β-HSD1对氧化甾醇和糖皮质激素的转化具有竞争性,7KC抑制糖皮质激素代谢的生理相关半数抑制浓度(IC50)范围为450纳米。作为11β-还原酶活性的抑制剂,7KC减少了活性糖皮质激素的再生,并限制了3T3-L1前脂肪细胞的分化过程。在反式激活试验中,7KC和7β-HC均未激活肝脏X受体,它们也未表现出糖皮质激素受体的内在激活。然而,当与糖皮质激素(10纳米)共同孵育时,7KC会抑制,而7β-HC会增强糖皮质激素受体转录活性。7-氧化甾醇的作用源于对11β-HSD1反应方向的调节,而己糖6-磷酸脱氢酶的过表达可改善这种作用,该酶为11β-HSD1提供还原型烟酰胺腺嘌呤二核苷酸磷酸。因此,在氧化甾醇过量的情况下,脂肪组织11β-HSD1的活性和反应方向会发生改变,这可能会影响肥胖及其并发症的病理生理学。